Back
Enlivex Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
ENLV
Sponsored
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
17
ENLV
Enlivex Therapeutics
Last Price:
1.06
Seasonality Move:
14.56%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereEnlivex Therapeutics Price Quote
$1.06
-0.01 (-1.85%)
(Updated: November 16, 2024 at 5:16 AM ET)
Enlivex Therapeutics Key Stats
Sell
17
Enlivex Therapeutics (ENLV)
is a Sell
Day range:
$1.01 - $1.10
52-week range:
$1.01 - $4.59
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.8%
Volume:
130.4K
Avg. volume:
148.3K
1-year change:
-38.86%
Market cap:
$22.9M
Revenue:
$0
EPS:
$-1.18
How Much Does Enlivex Therapeutics Make?
Data Unavailable
Is Enlivex Therapeutics Growing As A Company?
Data Unavailable
Enlivex Therapeutics Stock Price Performance
-
Did Enlivex Therapeutics Stock Go Up Last Month?
Enlivex Therapeutics share price went down by -30.97% last month -
Did ENLV's Share Price Rise Over The Last Year?
ENLV share price fell by -38.86% over the past 1 year
What Is Enlivex Therapeutics 52-Week High & Low?
-
What Is Enlivex Therapeutics’s 52-Week High Share Price?
Enlivex Therapeutics has traded as high as $4.59 over the past 52 weeks -
What Is Enlivex Therapeutics’s 52-Week Low Share Price?
Enlivex Therapeutics has traded as low as $1.01 over the past 52 weeks
Enlivex Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Enlivex Therapeutics?
-
How Much Debt Does Enlivex Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Enlivex Therapeutics Have?
Cash and short term investments quarterly total is $25.9M -
What Is Enlivex Therapeutics’s Book Value Per Share?
Book value per share is 1.37
Is Enlivex Therapeutics Cash Flow Positive?
-
What Is ENLV Cash Flow From Operations?
Cash flow from operations (TTM) is -$17M -
What Is Enlivex Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $4.9M -
What Is Enlivex Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $12.4M
Enlivex Therapeutics Return On Invested Capital
Data Unavailable
Enlivex Therapeutics Earnings Date & Stock Price
-
What Is Enlivex Therapeutics's Stock Price Today?
A single share of ENLV can be purchased today for 1.07 -
What Is Enlivex Therapeutics’s Stock Symbol?
Enlivex Therapeutics trades on the nasdaq under the ticker symbol: ENLV -
When Is Enlivex Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Enlivex Therapeutics is scheduled on August 29, 2025 -
When Is ENLV's next ex-dividend date?
Enlivex Therapeutics's next ex-dividend date is November 18, 2024 -
How To Buy Enlivex Therapeutics Stock?
You can buy Enlivex Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Enlivex Therapeutics Competitors
-
Who Are Enlivex Therapeutics's Competitors?
Below is a list of companies who compete with Enlivex Therapeutics or are related in some way:
Enlivex Therapeutics Dividend Yield
-
What Is ENLV Dividend Yield?
Enlivex Therapeutics’s dividend yield currently is 0% -
What Is Enlivex Therapeutics’s Payout Ratio?
Enlivex Therapeutics’s payout ratio is 0% -
When Did Enlivex Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 18, 2024 -
What Is Enlivex Therapeutics’s Dividend Per Share?
Enlivex Therapeutics pays a dividend of $0.00 per share
Enlivex Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -100% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 9.50 |
Upside from Last Price: | 787.85% |